| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/10/2006 | WO2006082222A1 Compositions comprising epigallocatechin gallate and protein hydrolysate |
| 08/10/2006 | WO2006082221A1 Drug delivery materials made by sol/gel technology |
| 08/10/2006 | WO2006082185A1 Novel 6-pyridylphenanthridines |
| 08/10/2006 | WO2006082151A2 Synergistic mixtures of c6- to c12-alkanediols and tropolone (derivatives) |
| 08/10/2006 | WO2006082129A1 Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis |
| 08/10/2006 | WO2006082107A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 08/10/2006 | WO2006082097A1 Method for the production of a tamper-proof form of administration |
| 08/10/2006 | WO2006082093A1 Process for the preparation of fatty acids |
| 08/10/2006 | WO2006082089A1 Oral dosage form comprising rosiglitazone |
| 08/10/2006 | WO2006082088A1 Ester-linked gemini surfactant compounds for use in gene therapy |
| 08/10/2006 | WO2006082077A1 Natural remedy-dietary supplement combination product |
| 08/10/2006 | WO2006082073A1 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints |
| 08/10/2006 | WO2006082072A1 Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis |
| 08/10/2006 | WO2006082071A1 Method for producing a drug extract that contains hydroxystilbene |
| 08/10/2006 | WO2006082068A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 08/10/2006 | WO2006082053A1 7-ethyl-10-hydroxy-camptothecin lipid ester derivatives |
| 08/10/2006 | WO2006082046A1 Use of s-clenbuterol |
| 08/10/2006 | WO2006082030A1 New 4-aminoquinoline derivatives as antimalarials |
| 08/10/2006 | WO2006082010A1 Inhibitors of diacylglycerol acyltransferase (dgat) |
| 08/10/2006 | WO2006082002A1 Imidazole derivatives |
| 08/10/2006 | WO2006081997A2 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy |
| 08/10/2006 | WO2006081994A2 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
| 08/10/2006 | WO2006081986A1 Bambuterol and integrin inhibitor combination |
| 08/10/2006 | WO2006081985A1 Combined treatment with an n4-(substituted-oxycarbonyl)-5’-deoxy-5-fluorocytidine derivative and an epidermal growth factor receptor kinase inhibitor |
| 08/10/2006 | WO2006081794A1 Dietary food |
| 08/10/2006 | WO2006081771A1 Artemisine (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same |
| 08/10/2006 | WO2006081743A1 Medicament for treating cervical erosion and method for its preparation |
| 08/10/2006 | WO2006081741A1 Quinazoline compounds or their medical salts and preparation and medical usage thereof |
| 08/10/2006 | WO2006081740A1 The synergistically pharmaceutical composition of baicalein and baicalin for inhibiting tumor |
| 08/10/2006 | WO2006081739A1 A composition for treating or preventing hyperlipemia, hypertension and hepatic adipose infiltration |
| 08/10/2006 | WO2006081669A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | WO2006081665A1 Purine nucleoside analogs |
| 08/10/2006 | WO2006081659A1 Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k) |
| 08/10/2006 | WO2006081658A1 In silico screening for shbg binding ligands via pharmacophore models |
| 08/10/2006 | WO2006081631A1 Adjuvanting material |
| 08/10/2006 | WO2006081616A1 Classes of compounds that interact with integrins |
| 08/10/2006 | WO2006070208A8 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists |
| 08/10/2006 | WO2006069276A3 TRICYCLIC ō-OPIOID MODULATORS |
| 08/10/2006 | WO2006069208A3 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 08/10/2006 | WO2006069193A3 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 08/10/2006 | WO2006066121A3 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 08/10/2006 | WO2006066067A3 Formulations of bisphosphonate drugs with improved bioavailability |
| 08/10/2006 | WO2006066020A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/10/2006 | WO2006065828A3 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 08/10/2006 | WO2006065792A3 Treatment of interstitial cystitis using cannabinoid analogs |
| 08/10/2006 | WO2006065721A3 11, 12-lactone bicyclolides |
| 08/10/2006 | WO2006063078A3 Topiramate pharmaceuticals composition |
| 08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
| 08/10/2006 | WO2006061791A3 Novel diazabicyclononene derivative |
| 08/10/2006 | WO2006060109B1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/10/2006 | WO2006058628A3 Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes |
| 08/10/2006 | WO2006058007A3 Jnk inhibitors for treatment of cns injury |
| 08/10/2006 | WO2006055404A3 Compounds for targeting mechanisms implicated in the progression of stroke |
| 08/10/2006 | WO2006055216A3 Vulnerable plaque treatment |
| 08/10/2006 | WO2006053778A3 Amide derivatives, their manufacture and use as pharmaceutical agents |
| 08/10/2006 | WO2006053186A3 Method for treatment of movement disorders |
| 08/10/2006 | WO2006052496A3 Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
| 08/10/2006 | WO2006050544A3 Tolperison for treating dogs having degenerative spinal symptoms |
| 08/10/2006 | WO2006050359A3 Pyridazine compounds and methods |
| 08/10/2006 | WO2006047714A3 Sustained release of active molecules from polymers topically applied to skin or hair |
| 08/10/2006 | WO2006047671A3 4-aminotetracyclines and methods of use thereof |
| 08/10/2006 | WO2006047575A3 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 08/10/2006 | WO2006046112A3 Ketolide derivatives as antibacterial agents |
| 08/10/2006 | WO2006044602A3 Diphenyl substituted alkanes as flap inhiibitors |
| 08/10/2006 | WO2006044415A3 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 08/10/2006 | WO2006043149A9 Novel dicarboxylic acid derivatives |
| 08/10/2006 | WO2006042277A3 Extended release compositions of proton pump inhibitors |
| 08/10/2006 | WO2006040318A3 Pi3 kinase gamma inhibitors for the treatment of anaemia |
| 08/10/2006 | WO2006039356A3 Substituted n-aryl-9-oxo-9h-fluorene-1-carboxamides and analogs as activators of caspases and inducers of apoptosis |
| 08/10/2006 | WO2006037024A3 Salts of decitabine |
| 08/10/2006 | WO2006036879A3 Chimeric gb virus b (gbv-b) |
| 08/10/2006 | WO2006034451A3 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 08/10/2006 | WO2006034440A3 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 08/10/2006 | WO2006033795A3 Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth |
| 08/10/2006 | WO2006026608A3 Transgenic mammals and cell lines for the identification of glutamate transporter modulators |
| 08/10/2006 | WO2006026356A3 S-TRIAZOLYL α-MERCAPTOACETANILDES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE |
| 08/10/2006 | WO2006024947A3 Methods and materials relating to enhanced production of dopamine neurons |
| 08/10/2006 | WO2006024492A3 Medical implant provided with inhibitors of atp synthesis |
| 08/10/2006 | WO2006024490A3 Methods and compositions for the treatment of cell proliferation |
| 08/10/2006 | WO2006024489A3 Methods and compositions for the treatment of cell proliferation |
| 08/10/2006 | WO2006023714A3 Dithiocarbamate derivatives and their use for treating cancer |
| 08/10/2006 | WO2006021811A3 Treatment of posterior capsule opacification |
| 08/10/2006 | WO2006021653A3 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 08/10/2006 | WO2006019429A3 Methods of identifying and using agents that increase inhibition of or resistance to hcv infection |
| 08/10/2006 | WO2006018850A3 Compositions for treating amyloid associated diseases |
| 08/10/2006 | WO2006018807A8 Crystalline forms of cefdinir |
| 08/10/2006 | WO2006017055A3 Pyrazole amide derivatives, compositions containing such compounds and methods of use |
| 08/10/2006 | WO2006016904A3 Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock |
| 08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
| 08/10/2006 | WO2005123069A3 Gram-positive carbapenem antibacterials and processes for their preparation |
| 08/10/2006 | WO2005122739A3 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 08/10/2006 | WO2005121215A3 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 08/10/2006 | WO2005117843A3 Sustained release preparations |
| 08/10/2006 | WO2005115455A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 08/10/2006 | WO2005110406A3 Phenyl derivatives for the treatment of abnormal cell growth |
| 08/10/2006 | WO2005102305A3 Compositions of allosteric hemoglobin modifiers and methods of making the same |
| 08/10/2006 | WO2005097103A3 Diabetes and metabolic syndrome therapy utilizing cathepsin b inhibitors |
| 08/10/2006 | WO2005094840A8 Compositions comprising mannose phosphate for vaginal treatment |
| 08/10/2006 | WO2005086804A3 Modulation of ace2 expression |
| 08/10/2006 | WO2005079496A3 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |